Literature DB >> 2486192

Pharmacokinetics from a dynamical systems point of view.

J M van Rossum1, J E de Bie, G van Lingen, H W Teeuwen.   

Abstract

The pharmacological action of many drugs depends on several variables at the same time and therefore will be dominated by an attractor of a dimension greater than zero. The pharmacokinetic behavior is likely to be dominated by a zero dimensional point attractor so that it is highly predictable. Pharmacokinetics is discussed from a dynamical systems point of view, whereby the transport of drugs in the tissues and organs is considered a stochastic process characterized by density functions of transit times and blood flows. In the body, the tissues and organs are arranged in parallel, in series, and in a feedback-loop fashion. Consequently, the single-pass transport of drugs through the body is again a stochastic process characterized by the density function of total body transit times, the cardiac output, and the total body extraction. The drug molecules, however, may pass through the body several times before ultimately leaving the system by metabolism or excretion. As a result, the body may be regarded as a positive feedback system with the pulmonary circulation (and its tissues) as the forward transfer function and the systemic circulation (with all its tissues) as the feedback transfer function. Consequently, the total body transport function (closed loop) is again a stochastic process characterized by a density function of total body residence times. The relationship between the body transit time distribution and the body residence distribution is determined by the feedback-loop arrangement, the cardiac output, and the extraction ratio which can easily be written in the Laplace domain. The pharmacokinetic parameters logically follow from the systems approach. They are the cardiac output, the mean transit time, the extraction ratio, the clearance, the volume of distribution in steady state, the mean residence time, and the average number of recirculations. The dynamic systems approach in pharmacokinetics has been illustrated with some examples notably with caffeine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2486192     DOI: 10.1007/bf01061902

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  20 in total

Review 1.  Applications of a recirculatory stochastic pharmacokinetic model: limitations of compartmental models.

Authors:  D P Vaughan; I Hope
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

2.  A linear recirculation model for drug disposition.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

3.  Pharmacokinetics of intravenous theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

4.  Recirculatory moment analysis of drugs in man: estimation of extraction ratio and mean cycle time for single systemic and pulmonary circulation.

Authors:  K Yamaoka; T Nakagawa; H Tanaka
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-02       Impact factor: 1.645

5.  Modelling of initial distribution of drugs following intravenous bolus injection.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Interindividual variability in the metabolism and cardiovascular effects of nicotine in man.

Authors:  N L Benowitz; P Jacob; R T Jones; J Rosenberg
Journal:  J Pharmacol Exp Ther       Date:  1982-05       Impact factor: 4.030

7.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

8.  Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration.

Authors:  M D Rawlins; D B Henderson; A R Hijab
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

9.  Physiologic and temporal variation in hepatic elimination of midazolam.

Authors:  U Klotz; G Ziegler
Journal:  Clin Pharmacol Ther       Date:  1982-07       Impact factor: 6.875

10.  Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults.

Authors:  S M Huang; N K Athanikar; K Sridhar; Y C Huang; W L Chiou
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more
  12 in total

1.  Sensitivity analysis of pharmacokinetic and pharmacodynamic systems: I. A structural approach to sensitivity analysis of physiologically based pharmacokinetic models.

Authors:  I A Nestorov
Journal:  J Pharmacokinet Biopharm       Date:  1999-12

2.  Dynamics of drug distribution. I. Role of the second and third curve moments.

Authors:  M Weiss; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1992-06

3.  Evaluation of hepatic function using the pharmacokinetics of a therapeutically administered drug. Application to the immunosuppressant cyclosporin.

Authors:  W Weber; M Looby; J Brockmöller
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

4.  Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam.

Authors:  J G Wagner; D A Ganes; K K Midha; I Gonzalez-Younes; J C Sackellares; L D Olson; M B Affrime; J E Patrick
Journal:  J Pharmacokinet Biopharm       Date:  1991-08

5.  Addendum to the commentary to "Pharmacokinetics from a Dynamical Systems Point of View".

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1990-06

6.  Investigation of absorption kinetics by the phase plane method.

Authors:  A Dokoumetzidis; P Macheras
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

7.  Frequency response method in pharmacokinetics.

Authors:  L Dedík; M Durisová
Journal:  J Pharmacokinet Biopharm       Date:  1994-08

8.  Lumping of whole-body physiologically based pharmacokinetic models.

Authors:  I A Nestorov; L J Aarons; P A Arundel; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1998-02

Review 9.  Fractal geometry, fractal kinetics and chaos en route to biopharmaceutical sciences.

Authors:  P Macheras; P Argyrakis; C Polymilis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

10.  Importance of early blood sampling on vecuronium pharmacokinetic and pharmacodynamic parameters.

Authors:  J Ducharme; F Varin; D R Bevan; F Donati
Journal:  Clin Pharmacokinet       Date:  1993-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.